Page 125 - Read Online
P. 125

antiretroviral treatment and correlation with risk of hospitalization   of therapeutic alliance and insight on medication adherence in
             among commercially insured HIV patients in the United States.   schizophrenia. Nord J Psychiatry 2012;66:49-54.
             PLoS One 2012;7:e31591.                          43.  Spiekermann A, Schulz M, Behrens J, Driessen M, Rahn E,
          37.  Denis DJ. Applied univariate, bivariate, and multivariate   Beblo T. Adherence and cognitive performance in schizophrenia.
             statistics. Hoboken, NJ: John Wiley and Sons; 2015.  Fortschr Neurol Psychiatr 2011;79:73-82.
          38.  Stein-Shvachman I, Karpas DS, Werner P. Depression treatment   44.  Paulhus DL, Vazire S. The self-report method. In: Robins RW,
             non-adherence and its psychosocial predictors: differences   Fraley RC, Krueger RF, editors. Handbook of research methods in
             between young and older adults? Aging Dis 2013;4:329-36.  personality psychology. New York, NY: Guilford; 2007. p. 224-39.
          39.  Steger KA, Cassidy C, Rabinovitch M, Joober R, Malla A. Impact   45.  van de Mortel TF. Faking it: social desirability response bias in
             of symptom resolution on medication adherence in first episode   self-report research. Aust J Adv Nurs 2008;25:40-8
             psychosis. Psychiatry Res 2012;196:45-51.        46.  Pitschel-Walz G,  Bäuml J,  Bender W, Engel RR, Wagner M,
          40.  Quach PL, Mors O, Christensen TØ, Krarup G, Jørgensen P,   Kissling W. Psychoeducation and compliance in the treatment
             Bertelsen  M,  Jeppesen  P,  Petersen  L,  Thorup  A,  Nordentoft   of schizophrenia: results of the Munich Psychosis Information
             M. Predictors of poor adherence to medication among patients   Project Study. J Clin Psychiatry 2006;67:443-52.
             with first episode schizophrenia spectrum disorder. Early Interv   47.  Levin KA. Study design III: cross-sectional studies. Evid Based
             Psychiatry 2009;3:66-74.                            Dent 2006;7:24-5.
          41.  Tattan TM, Creed FH. Negative symptoms of schizophrenia and   48.  Mann CJ. Observational research methods. Research design II:
             compliance with medication. Schizophr Bull 2001;27:149-55.  cohort, cross sectional, and case-control studies. Emerg Med J
          42.  Misdrahi D, Petit M, Blanc O, Bayle F, Llorca PM. The influence   2003;20:54-60.





































































           116                                                       Neuroimmunol Neuroinflammation | Volume 3 | May 20, 2016
   120   121   122   123   124   125   126   127   128   129   130